GSK2862277
GSK2862277 is a human monoclonal antibody (mAb) targeting TNFRSF1A. GSK2862277 increases neutrophil extracellular trap formation and alveolar macrophage phagocytosis. GSK2862277 can be used in Acute lung injury and Acute Respiratory Distress Syndrome (ARDS) research. Recommended isotype control: VHH-hFc[1].
Product Specifications
UNSPSC
12352203
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
[GSK2862277]
References & Citations
[1]Howells P A. Oesophagectomy as a model of the Acute Respiratory Distress Syndrome[D]. University of Birmingham, 2019.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
TNFRSF1A/CD120a
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6374520-01 0.1 mL
COX5A (Cytochrome C Oxidase Subunit 5A, Mitochondrial, Cytochrome C Oxidase Polypeptide Va) (MaxLight 750)
Ask
View Details 
MBS6374520-02 5x 0.1 mL
COX5A (Cytochrome C Oxidase Subunit 5A, Mitochondrial, Cytochrome C Oxidase Polypeptide Va) (MaxLight 750)
Ask
View Details